| Issue Date | Title | Author(s) |
1 | 2014 | Altered vasoactive peptide composition in the tissues of Cathepsin A deficient mice | Timur, Zehra; Akyıldız Demir, Seçil; Çalhan, Y.; Korak, Tuğcan; Ateş, Edanur; Seyrantepe, Volkan |
2 | 2020 | Brain lipid profile of early onset Tay-Sachs disease mouse model | Şengül, Tuğçe; Can, Melike; Akyıldız Demir, Seçil; Klose, C.; Surma, M.; Seyrantepe, Volkan |
3 | 2023 | Elimination of the B4Galnt1 gene normalizes lifespan and prevents pathology in Tay-Sachs disease mice | Seyrantepe, Volkan |
4 | 2024 | Gangliosides as Therapeutic Targets for Neurodegenerative Diseases | Inci, Orhan Kerim; Basirli, Hande; Can, Melike; Yanbul, Selman; Seyrantepe, Volkan |
5 | 2023 | Investigating the efficacy of combined ketogenic diet and anti-inflammatory therapy in a mouse model of early-onset Tay-Sachs disease | inci, Orhan Kerim; Seyrantepe, Volkan |
6 | 2014 | Mass spectrometry and thin layer chromatography analysis of brain gangliosides in Tay-Sachs disease mouse models | Seyrantepe, Volkan ; Timur, Zehra; Marsching, C.; Sandhoff, Roger |
7 | 2020 | Role of oxidative stress in the pathogenesis of Tay-Sachs disease mouse model | Ateş, Nurselin ; Başırlı, Hatice Hande; Çalışkan, Tufan Utku; Nalbant, Ayten ; Seyrantepe, Volkan |
8 | 2024 | Treatment with recombinant human lysosomal ßhexosaminidase reduces GM2 accumulation in Tay-Sachs disease cells | Inci, Orhan Kerim; Leal, Andres F.; Ates, Nurselin ; Suarez, Diego; Espejo, Angela J.; Almeciga-Diaz, Carlos Javier; Seyrantepe, Volkan |